IOVA Crosses Above Average Analyst Target
December 11, 2020 at 08:42 AM EST
In recent trading, shares of Iovance Biotherapeutics Inc (IOVA) have crossed above the average analyst 12-month target price of $47.00, changing hands for $49.48/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..